## Core Concept
The management of mania, particularly in an Intensive Care Unit (ICU) setting, requires careful consideration of the patient's physical condition and potential drug interactions. The primary goal is to control symptoms of mania while minimizing risks. Pharmacological interventions often include mood stabilizers and antipsychotics.

## Why the Correct Answer is Right
In the ICU setting, the choice of medication for treating mania is limited by the need to avoid drugs that may have significant side effects, such as respiratory depression, or that may interact adversely with other ICU medications. Lithium, though effective for mania, is often avoided in the ICU due to its narrow therapeutic index and potential for nephrotoxicity, as well as the difficulty in managing its levels in a critically ill patient.

## Why Each Wrong Option is Incorrect
* **Option A:** This option is not provided, but typically, effective treatments for mania include antipsychotics like olanzapine, risperidone, and quetiapine, which can be used in the ICU with careful monitoring.
* **Option B:** Similarly, this option is not provided, but other treatments might include benzodiazepines for short-term management of agitation.
* **Option D:** Without specifics, it's hard to address directly, but generally, treatments that are effective and can be used cautiously in the ICU would be considered viable.

## Clinical Pearl / High-Yield Fact
A key consideration in the ICU is the potential for drug-drug interactions and the impact of critical illness on drug pharmacokinetics. For example, **antipsychotics like haloperidol** can be used in the ICU for managing agitation but require careful monitoring for side effects such as QT prolongation.

## Correct Answer: D. Lithium.